CXCL12 is pivotal in the initial stages of tumorigenesis, and studies have corroborated that fibroblast-derived CXCL12 consumption mitigates tumor cell proliferation while recruiting endothelial progenitor cells to the TME, thus expanding tumor vessels [39]. The gene discussed is CXCL12; the disease is neoplasm.